Marina Talamonti

14.4k total citations · 1 hit paper
208 papers, 8.3k citations indexed

About

Marina Talamonti is a scholar working on Oncology, Immunology and Dermatology. According to data from OpenAlex, Marina Talamonti has authored 208 papers receiving a total of 8.3k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Oncology, 64 papers in Immunology and 54 papers in Dermatology. Recurrent topics in Marina Talamonti's work include Psoriasis: Treatment and Pathogenesis (62 papers), Pancreatic and Hepatic Oncology Research (60 papers) and Dermatology and Skin Diseases (52 papers). Marina Talamonti is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (62 papers), Pancreatic and Hepatic Oncology Research (60 papers) and Dermatology and Skin Diseases (52 papers). Marina Talamonti collaborates with scholars based in United States, Italy and Japan. Marina Talamonti's co-authors include David J. Bentrem, Karl Y. Bilimoria, Clifford Y. Ko, Andrew K. Stewart, David P. Winchester, Marco Galluzzo, Luca Bianchi, Marshall S. Baker, Michael Ujiki and Sambasiva Rao and has published in prestigious journals such as Nature Genetics, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Marina Talamonti

202 papers receiving 8.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma

2015 1.2k citations David J. Bentrem, Marina Talamonti et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marina Talamonti United States	46	4.8k	2.6k	2.0k	1.6k	1.5k	208	8.3k
Lee S. Schwartzberg United States	49	6.0k 1.3×	1.7k 0.7×	2.3k 1.1×	789 0.5×	1.5k 1.0×	422	10.2k
Deborah Stocken United Kingdom	37	5.2k 1.1×	3.2k 1.2×	2.0k 1.0×	851 0.5×	1.6k 1.0×	118	9.4k
Ashley E. Winkler United States	10	3.9k 0.8×	1.4k 0.5×	2.5k 1.2×	469 0.3×	848 0.6×	12	7.3k
Andreas du Bois Germany	61	6.4k 1.3×	5.4k 2.1×	2.0k 1.0×	718 0.5×	2.7k 1.8×	445	15.8k
Isabelle Ray‐Coquard France	64	7.0k 1.5×	3.6k 1.4×	5.5k 2.7×	1.8k 1.2×	1.8k 1.2×	418	16.7k
Howard Gurney Australia	44	5.9k 1.2×	2.9k 1.1×	3.4k 1.6×	844 0.5×	1.4k 0.9×	286	9.5k
Jeffrey Crawford United States	48	6.8k 1.4×	686 0.3×	2.8k 1.4×	581 0.4×	731 0.5×	206	10.2k
Scott Wadler United States	43	4.5k 0.9×	1.9k 0.7×	1.9k 0.9×	519 0.3×	610 0.4×	192	8.1k
David Khayat France	38	5.3k 1.1×	1.1k 0.4×	2.6k 1.3×	511 0.3×	1.4k 1.0×	108	8.4k
Patricia Keegan United States	54	5.0k 1.0×	726 0.3×	3.1k 1.5×	1.3k 0.8×	1.6k 1.1×	140	9.3k

Countries citing papers authored by Marina Talamonti

Since Specialization

Citations

This map shows the geographic impact of Marina Talamonti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marina Talamonti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marina Talamonti more than expected).

Fields of papers citing papers by Marina Talamonti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marina Talamonti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marina Talamonti. The network helps show where Marina Talamonti may publish in the future.

Co-authorship network of co-authors of Marina Talamonti

This figure shows the co-authorship network connecting the top 25 collaborators of Marina Talamonti. A scholar is included among the top collaborators of Marina Talamonti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marina Talamonti. Marina Talamonti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Talamonti, Marina, et al.. (2025). Effects of Guselkumab on the FIB ‐4 Index in Psoriasis Patients ( EGIPT ): A Three‐Year Study. The Journal of Dermatology. 52(6). 1113–1117.

Talamonti, Marina, et al.. (2024). Efficacy and Safety of Dupilumab in the Treatment of Hand Eczema: A Retrospective Study. Journal of Clinical Medicine. 13(7). 1876–1876. 4 indexed citations

Talamonti, Marina, et al.. (2024). Characterization of Super-Responder Profile in Chronic Plaque Psoriatic Patients under Guselkumab Treatment: A Long-Term Real-Life Experience. Journal of Clinical Medicine. 13(17). 5175–5175. 4 indexed citations

Galluzzo, Marco, Marina Talamonti, Luca Bianchi, et al.. (2024). Dupilumab-Associated Ocular Surface Disease or Atopic Keratoconjunctivitis Not Improved by Dupilumab? Upadacitinib May Clarify the Dilemma: A Case Report. SHILAP Revista de lepidopterología. 4(3). e354–e354. 2 indexed citations

Russo, Filomena, Nicola Milanesi, Marco Galluzzo, et al.. (2024). Evaluating the Clinical Meaning of Dermatology Life Quality Index Scores between Different Phenotypes of Atopic Dermatitis in Patients before and after Biologic Therapy with Dupilumab. Dermatitis. 36(2). 161–166. 1 indexed citations

Vitello, Dominic & Marina Talamonti. (2024). Modern Treatment Strategies for Borderline Resectable Pancreatic Cancer. Cancer treatment and research. 192. 67–88. 1 indexed citations

Galluzzo, Marco, et al.. (2023). Guselkumab for treatment of moderate-to-severe plaque psoriasis: real-life effectiveness and drug-survival for up to 148 weeks. Expert Opinion on Biological Therapy. 23(4). 371–381. 12 indexed citations

Talamonti, Marina, et al.. (2021). Quality of Life and Psychological Impact in Patients with Atopic Dermatitis. Journal of Clinical Medicine. 10(6). 1298–1298. 36 indexed citations

Galluzzo, Marco, et al.. (2020). Use of Guselkumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: A 1 Year Real-Life Study. Journal of Clinical Medicine. 9(7). 2170–2170. 58 indexed citations

10.

Galluzzo, Marco, S. D’Adamio, Maria Sole Chimenti, et al.. (2019). Successful treatment of psoriatic crumbly nails with ustekinumab. Dermatologic Therapy. 32(3). e12914–e12914. 4 indexed citations

11.

Talamonti, Marina, Darren S. Bryan, Chi-Hsiung Wang, et al.. (2018). Does adjuvant radiation provide any survival benefit after an R1 resections for pancreatic cancer?. Surgery. 163(5). 1047–1052. 8 indexed citations

12.

Marsh, Robert, Marina Talamonti, Marshall S. Baker, et al.. (2017). Primary systemic therapy in resectable pancreatic ductal adenocarcinoma using mFOLFIRINOX: A pilot study. Journal of Surgical Oncology. 117(3). 354–362. 26 indexed citations

13.

Talamonti, Marina, Marco Galluzzo, Miriam Teoli, et al.. (2013). Pharmacogenetics of psoriasis:HLA-Cw6but notLCE3B/3Cdeletion norTNFAIP3polymorphism predisposes to clinical response to interleukin 12/23 blocker ustekinumab. British Journal of Dermatology. 169(2). 458–463. 110 indexed citations

14.

Teoli, Miriam, Arianna Zangrilli, Maria Sole Chimenti, et al.. (2012). Evaluation of Clinical and Ultrasonographic Parameters in Psoriatic Arthritis Patients Treated with Adalimumab: A Retrospective Study. SHILAP Revista de lepidopterología. 2012. 1–6. 10 indexed citations

15.

Baker, Marshall S., David J. Bentrem, Michael Ujiki, Susan J. Stocker, & Marina Talamonti. (2011). Adding days spent in readmission to the initial postoperative length of stay limits the perceived benefit of laparoscopic distal pancreatectomy when compared with open distal pancreatectomy. The American Journal of Surgery. 201(3). 295–300. 34 indexed citations

16.

Papoutsaki, Marina, Marina Talamonti, Alessandro Giunta, et al.. (2010). The Impact of Methodological Approaches for Presenting Long-Term Clinical Data on Estimates of Efficacy in Psoriasis Illustrated by Three-Year Treatment Data on Infliximab. Dermatology. 221(Suppl. 1). 43–47. 19 indexed citations

17.

Esposito, Maria, Alessandro Giunta, Annamaria Mazzotta, et al.. (2010). Continuous Treatment of Plaque-Type Psoriasis with Etanercept: An Observational Long-Term Experience. International Journal of Immunopathology and Pharmacology. 23(2). 503–509. 12 indexed citations

18.

Bilimoria, Karl Y., David J. Bentrem, Keith D. Lillemoe, Marina Talamonti, & Clifford Y. Ko. (2009). Assessment of Pancreatic Cancer Care in the United States Based on Formally Developed Quality Indicators. JNCI Journal of the National Cancer Institute. 101(12). 848–859. 92 indexed citations

19.

Small, William, Steven J. Stryker, Krystyna Kiel, et al.. (2007). Preoperative chemoradiation for rectal cancer: results of multimodality management and analysis of prognostic factors. The American Journal of Surgery. 193(3). 389–394. 52 indexed citations

20.

Yao, Katherine, Marina Talamonti, Albert A. Nemcek, et al.. (2001). Indications and results of liver resection and hepatic chemoembolization for metastatic gastrointestinal neuroendocrine tumors. Surgery. 130(4). 677–685. 170 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact